Tidal Therapeutics is a preclinical biotech company focused on developing nanoparticles that deliver mRNA to reprogram immune cells inside the body with applications in oncology and immune diseases.

Sectors
Healthcare
Life Sciences
First Invested
2019
Early
Company Status
Acquired
Acquired by Sanofi
Associated Team
Ali Behbahani, MD